DMD and Menkes disease: Taking a forward and wider look into the future of DAC therapy, the development of iPSCs and genome editing technologies has opened up the possibility to correct DMD mutations in patient-specific iPSCs followed by their differentiation into muscle precursor cells or cardiomyocytes that can be transplanted into MD patients [162,201,253].